[1] | HENSON D E, SCHWARTZ A M, NSOULI H, et al.Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a populationbased study[J]. Arch Pathol Lab Med, 2009, 133(1): 67-71. | [2] | ITO K, FUJITA N, NODA Y, et al.Diagnosis of ampullary cancer[J]. Dig Surg, 2010, 27(2): 115-118. | [3] | KANG S P, SAIF M W.Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the “2011 ASCO Gastrointestinal Cancers Symposium”. San Francisco, CA, USA. January 20-22, 2011[J]. Jop, 2011, 12(2): 123-125. | [4] | PERYSINAKIS I, MARGARIS I, KOURAKLIS G.Ampullary cancer—a separate clinical entity?[J]. Histopathology, 2014, 64(6): 759-768. | [5] | ASANO E, OKANO K, OSHIMA M, et al.Phenotypic char acterization and clinical outcome in ampullary adenocarcinoma[J]. J Surg Onco, 2016, 114(1): 119-127. | [6] | LEO J M, KALLOGER S E, PEIXOTO R D, et al.Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups[J]. J Clin Pathol, 2016, 69(5): 431-439. | [7] | OVERMAN M J, ZHANG J, KOPETZ S, et al.Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome[J]. Plos One, 2013, 8(6): e65144-e65144. | [8] | WESTGAARD A, POMIANOWSKA E, CLAUSEN O P, et al.Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?[J]. Ann Surg Oncol, 2013, 20(2): 430-439. | [9] | ERDMANN J I, ESKENS F A L M, VOLLMER C M, et al. Histological and molecular subclassification of pancreatic and nonpancreatic periampullary cancers: implications for (Neo) adjuvant systemic treatment[J]. Ann Surg Oncol, 2015, 22(7): 2401-2407. | [10] | FERNANDEZ MORO C, FERNANDEZ-WOODBRIDGE A, Alistair D’souza M, et al.Immunohistochemical typing of adenocarcinomas of the pancreatobiliary system improves diagnosis and prognostic stratification[J]. PLoS One, 2016, 11(11): e0166067. | [11] | YUN S P, SEO H I.Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer[J]. BMC Gastroenterology, 2015, 15: 165-165. | [12] | PERYSINAKIS I, MINAIDOU E, LEONTARA V, et al.Differential expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in intestinal and pancreatobiliary-type ampullary carcinomas[J]. Int J Surg Pathol, 2017, 25(1): 31-40. | [13] | DACHA S, CHAWLA S, LEE J E, et al.Endoscopic retrograde cholangiopancreatography with ampullary biopsy vs ERCP alone: a matched-pairs controlled evaluation of outcomes and complications[J]. Gastroenterol Rep (Oxf), 2017. [Epub ahead of print] | [14] | TRIKUDANATHAN G, NJEI B, ATTAM R, et al.Staging accuracy of ampullary tumors by endoscopic ultrasound: Meta analysis and systematic review[J]. Dig Endosc, 2014, 26(5): 617-626. | [15] | OGURA T, HARA K, HIJIOKA S, et al.Can endoscopic ultrasound-guided fine needle aspiration offer clinical benefit for tumors of the ampulla of vater?——an initial study[J]. Endoscopic Ultrasound, 2012, 1(2): 84-89. | [16] | 魏小丽, 董卫国. 超声内镜对壶腹部周围病变的诊断价值研究[J]. 临床消化病杂志, 2016, 28(2): 71-75. | [17] | 孙风林. 56例原发性十二指肠肿瘤术式选择与分析[J]. 中华普外科手术学杂志(电子版), 2010, 4(3): 312-315. | [18] | 许邦文, 霍宗红, 佟艳春, 等. 壶腹部肿瘤局部切除20例分析[J]. 中华普外科手术学杂志(电子版), 2013, 7(2): 137-139. | [19] | 徐常力, 李赞滨, 邱法波, 等. 壶腹部肿瘤局部切除术式的改进[J]. 中华普外科手术学杂志(电子版), 2014, 8(4): 40-43. | [20] | ONKENDI E, NAIK N, ROSEDAHL J, et al.Adenomas of the ampulla of vater: a comparison of outcomes of operative and endoscopic resections[J]. J Gastrointest Surg, 2014, 18(9): 1588-1596. | [21] | MANSUKHANI V M, DESAI G S, MOULI S, et al.Transduodenal ampullectomy for ampullary tumors[J]. Indian J Gastroenterol , 2017, 36(1): 62-65. | [22] | DUBOIS M, LABGAA I, DORTA G, et al.Endoscopic and surgical ampullectomy for non-invasive ampullary tumors: Short-term outcomes[J]. Bioscience Trends, 2017, 10(6): 507-511. | [23] | MENDON?A E Q, BERNARDO W M, MOURA EGHD, et al. Endoscopic versus surgical treatment of ampullary adenomas: a systematic review and meta-analysis[J]. Clinics (Sao Paulo, Brazil), 2016, 71(1): 28-35. | [24] | BOURGOUIN S, EWALD J, MANCINI J, et al.Predictors of Survival in Ampullary, Bile Duct and Duodenal Cancers Following Pancreaticoduodenectomy: a 10-Year Multicentre Analysis[J]. J Gastrointestinal Surg, 2015, 19(7): 1247-1255. | [25] | CHANDRASEGARAM M D, CHEN J W, PRICE T J, et al.Advances in molecular pathology and treatment of periampullary cancers[J]. Pancreas, 2016, 45(1): 32-39. | [26] | CLOYD J M, WANG H, OVERMAN M, et al.Influence of preoperative therapy on short- and long-term outcomes of patients with adenocarcinoma of the ampulla of Vater[J]. Ann Surg Oncol, 2017. [Epub ahead of print] |
|